Want to join the conversation?
During 3Q15, $HALO enrolled more than 100 patients in Stage 2 of Study 202 of investigational new drug PEGPH20 in metastatic pancreatic ductal adenocarcinoma patients. Further, the company plans to complete its target enrollment of 114 patients by the end of 2015 and present results of the study in 2H16.
$DB is going to cut off services for about 3,400 clients in equities trading.
$F stock slid more than 2% after the company issued two safety recalls involving more than 650,000 Ford Fusion and Lincoln MKZ model cars.
The new CEO of $SBUX, Kevin Johnson, has some pretty large shoes to fill but there are many who have good faith in his ability to do so.
$TSLA opening a showroom in Michigan. A bold move !!